Endothelial cells and pulmonary arterial hypertension: Apoptosis, proliferation, interaction and transdifferentiation

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Sakao, Seiichiro ^a   Tatsumi, Koichiro ^a   Voelkel, Norbert F ^b  

^a CHIBA UNIVERSITY   (Japan)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEMAXANIB;

APOPTOSIS; CELL INTERACTION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; ENDOTHELIUM CELL; HUMAN; MESENCHYME CELL; PULMONARY HYPERTENSION; REVIEW; SMOOTH MUSCLE FIBER; ANIMAL; CELL COMMUNICATION; DISEASE COURSE; GENETICS; HOSPITALIZATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY ARTERY; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; CELL COMMUNICATION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; DISEASE PROGRESSION; ENDOTHELIAL CELLS; HUMANS; HYPERTENSION, PULMONARY; MUSCLE, SMOOTH, VASCULAR; PULMONARY ARTERY; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

EID: 73949089232     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-95     Document Type: Review

References (93)

1. Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Herve P, Rainisio M, Simonneau G. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002, 40:780-788. 10.1016/S0735-1097(02)02012-0, 12204511.
2. Rimensberger PC, Spahr-Schopfer I, Berner M, Jaeggi E, Kalangos A, Friedli B, Beghetti M. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms. Circulation 2001, 103:544-548.
3. Tuder RM, Groves B, Badesch DB, Voelkel NF. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994, 144:275-285. 1887146, 7508683.
4. Hirose S, Hosoda Y, Furuya S, Otsuki T, Ikeda E. Expression of vascular endothelial growth factor and its receptors correlates closely with formation of the plexiform lesion in human pulmonary hypertension. Pathol Int 2000, 50:472-479. 10.1046/j.1440-1827.2000.01068.x, 10886723.
5. Nicolls MR, Taraseviciene-Stewart L, Rai PR, Badesch DB, Voelkel NF. Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J 2005, 26:1110-1118. 10.1183/09031936.05.00045705, 16319344.
6. Tuder RM, Cool CD, Yeager ME, Taraseviciene-Stewart L, Bull TM, Voelkel NF. The pathobiology of pulmonary hypertension. Clin Chest Med 2001, 22:405-418. 10.1016/S0272-5231(05)70280-X, 11590837.
7. Cool CD, Stewart JS, Werahera P, Miller GJ, Williams RL, Voelkel NF, Tuder RM. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol 1999, 155:411-419. 1866857, 10433934.
8. Sumpio BE, Riley JT, Dardik A. Cells in focus: endothelial cell. Int J Biochem Cell Biol 2002, 34:1508-1512. 10.1016/S1357-2725(02)00075-4, 12379270.
9. Fishman AP, Fishman MC, Freeman BA, Gimbrone MA, Rabinovitch M, Robinson D, Gail DB. Mechanisms of proliferative and obliterative vascular diseases: insights from the pulmonary and systemic circulations. NHLBI Workshop summary. Am J Respir Crit Care Med 1998, 158:670-674.
10. Ward JP. Hypoxic pulmonary vasoconstriction is mediated by increased production of reactive oxygen species. J Appl Physiol 2006, 101:993-995. 10.1152/japplphysiol.00480.2006, 16675614.
11. Weir EK, Archer SL. Counterpoint: Hypoxic pulmonary vasoconstriction is not mediated by increased production of reactive oxygen species. J Appl Physiol 2006, 101:995-998. 10.1152/japplphysiol.00480a.2006, 16902070.
12. Ameshima S, Golpon H, Cool CD, Chan D, Vandivier RW, Gardai SJ, Wick M, Nemenoff RA, Geraci MW, Voelkel NF. Peroxisome proliferatoractivated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circ Res 2003, 92:1162-1169. 10.1161/01.RES.0000073585.50092.14, 12714563.
13. Pi X, Yan C, Berk BC. Big mitogen-activated protein kinase (BMK1)/ERK5 protects endothelial cells from apoptosis. Circ Res 2004, 94:362-369. 10.1161/01.RES.0000112406.27800.6F, 14670836.
14. Teichert-Kuliszewska K, Kutryk MJ, Kuliszewski MA, Karoubi G, Courtman DW, Zucco L, Granton J, Stewart DJ. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res 2006, 98:209-217. 10.1161/01.RES.0000200180.01710.e6, 16357305.
15. Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, Mc Mahon G, Waltenberger J, Voelkel NF, Tuder RM. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 2001, 15:427-438. 10.1096/fj.00-0343com, 11156958.
16. Campbell AI, Zhao Y, Sandhu R, Stewart DJ. Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension. Circulation 2001, 104:2242-2248. 10.1161/hc4201.097838, 11684638.
17. Zhao YD, Campbell AI, Robb M, Ng D, Stewart DJ. Protective role of angiopoietin-1 in experimental pulmonary hypertension. Circ Res 2003, 92:984-991. 10.1161/01.RES.0000070587.79937.F0, 12690034.
18. Taraseviciene-Stewart L, Scerbavicius R, Choe KH, Cool C, Wood K, Tuder RM, Burns N, Kasper M, Voelkel NF. Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2006, 291:L668-L676. 10.1152/ajplung.00491.2005, 16698853.
19. Sakao S, Taraseviciene-Stewart L, Lee JD, Wood K, Cool CD, Voelkel NF. Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells. FASEB J 2005, 19:1178-1180.
20. Golpon H, Fadok V, Taraseviciens-Stewart L, Scerbavicius R, Sauer C, Welte T, Henson PM, Voelkel FN. Life after corpse engulfment: Phagocytosis of apoptotic cells leads to VEGF secretion and cell growth. FASEB J 2004, 18:1716-1718.
21. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267:1456. 10.1126/science.7878464, 7878464.
22. Henson PM, Bratton DL, Fadok VA. Apoptotic cell removal. Curr Biol 2001, 11:R795-R805. 10.1016/S0960-9822(01)00474-2, 11591341.
23. Fadok VA, Bratton DL, Henson PM. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest 2001, 108:957-962. 200959, 11581295.
24. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature 2000, 407:784-788. 10.1038/35037722, 11048729.
25. Partovian C, Adnot S, Raffestin B, Louzier V, Levame M, Mavier IM, Lemarchand P, Eddahibi S. Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats. Am J Respir Cell Mol Biol 2000, 23:762-771.
26. Masri FA, Xu W, Comhair SA, Asosingh K, Koo M, Vasanji A, Drazba J, Anand-Apte B, Erzurum SC. Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 2007, 293:L548-L554. 10.1152/ajplung.00428.2006, 17526595.
27. Rai PR, Cool CD, King JAC, Stevens T, Burns N, Winn RA, Kasper M, Voelkel NF. The cancer paradigm of severe pulmonary arterial hypertension. Am J Respir Crit Care Med 2008, 178:558-564. 10.1164/rccm.200709-1369PP, 2542431, 18556624.
28. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004, 104:2752-2760. 10.1182/blood-2004-04-1396, 15226175.
29. Ingram DA, Mead LE, Moore DB, Woodard W, Fenoglio A, Yoder MC. Vessel wall derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 2005, 105:2783-2786. 10.1182/blood-2004-08-3057, 15585655.
30. Lindahl P, Johansson BR, Levéen P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997, 277:242-245. 10.1126/science.277.5323.242, 9211853.
31. Hirschi K, Rohovsky SA, D'Amore PA. PDGF, TGF-β and heterotypic cell-cell interactions mediate the recruitment and differentiation of 10T1/2 cells to a smooth muscle cell fate. J Cell Biol 1998, 141:805-814. 10.1083/jcb.141.3.805, 2132737, 9566978.
32. Hellström M, Kalén M, Lindahl P, Abramsson A, Betsholtz C. Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999, 126:3047-3055.
33. Antonelli-Orlidge A, Saunders KB, Smith SR, D'Amore PA. An activated form of transforming growth factor beta is produced by co-cultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 1989, 86:4544-4548. 10.1073/pnas.86.12.4544, 287307, 2734305.
34. Asakawa H, Kobayashi T. The effect of co-culture with human smooth muscle cells on the proliferation, the IL-1 beta secretion, the PDGF production and tube formation of human aortic endothelial cells. Cell Biochem Funct 1999, 17:123-130. 10.1002/(SICI)1099-0844(199906)17:2<123::AID-CBF817>3.0.CO;2-3, 10377958.
35. Penttinen RP, Kobayashi S, Bornstein P. Transforming growth factor-β increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Proc Natl Acad Sci USA 1988, 85:1105-1108. 10.1073/pnas.85.4.1105, 279714, 3422482.
36. Majesky MW, Lindner V, Twardzik DR. Production of transforming growth factor β1. J Clin Invest 1991, 88:904-910. 10.1172/JCI115393, 295478, 1832175.
37. Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G, Emilie D. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995, 151:1628-1631.
38. Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992, 327:70-75. 10.1056/NEJM199207093270202, 1603138.
39. Mikhail G, Chester AH, Gibbs SR, Borland JAA, Banner NR, Yacoub MH. Role of vasoactive mediators in primary and secondary pulmonary hypertension. Am J Cardiol 1998, 82:254-255. 10.1016/S0002-9149(98)00296-3, 9678304.
40. Rabinovitch M. Elastase and the pathobiology of unexplained pulmonary hypertension. Chest 1998, 114:213-224.
41. Rubin LJ. Cellular and molecular mechanisms responsible for the pathogenesis of primary pulmonary hypertension. Pediatr Pulmonol Suppl 1999, 18:194-197. 10.1002/(SICI)1099-0496(1999)27:18+<194::AID-PPUL63>3.0.CO;2-6, 10093141.
42. Wagenvoort CA, Wagenvoort N. Primary pulmonary hypertension. A pathologic study of the lung vessels in 156 clinically diagnosed cases. Circulation 1970, 42:1163-1171.
43. Wohrley JD, Frid MG, Moiseeva EP, Orton EC, Belknap JK, Stenmark KR. Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media. J Clin Invest 1995, 96:273-281. 10.1172/JCI118031, 185198, 7615796.
44. Golpon HA, Geraci MW, Moore MD, Miller HL, Miller GJ, Tuder RM, Voelkel NF. HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema. Am J Pathol 2001, 158:955-966. 1850338, 11238043.
45. Tuder RM, Chacon M, Alger L, Wang J, Taraseviciene-Stewart L, Kasahara Y, Cool CD, Bishop AE, Geraci M, Semenza GL, Yacoub M, Polak JM, Voelkel NF. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol 2001, 195:367-374. 10.1002/path.953, 11673836.
46. Tuder RM, Cool CD, Geraci MW, Wang J, Abman SH, Wright L, Badesch D, Voelkel NF. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med 1999, 159:1925-1932.
47. Diez J, Fortuno M, Zalba G, Etayo J, Fortuno A, Ravassa S, Beaumont J. Altered regulation of smooth muscle cell proliferation and apoptosis in small arteries of spontaneously hypertensive rats. Eur Heart J 1998, 19:G29-G33.
48. Guevara N, Kim H, Antonova E, Chan L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat Med 1999, 5:335-339. 10.1038/6585, 10086392.
49. Malik N, Francis S, Holt C, Gunn J, Thomas G, Shepherd L, Chamberlain J, Newman C, Cumberland D, Crossman D. Apoptosis and cell proliferation after porcine coronary angioplasty. Circulation 1998, 98:1657-1665.
50. Pollman M, Hall J, Mann M, Zhang L, Gibbons G. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat Med 1998, 4:222-227. 10.1038/nm0298-222, 9461197.
51. Sata M, Perlman H, Muruve D, Silver M, Ikebe M, Libermann T, Oettgen P, Walsh K. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc Natl Acad Sci USA 1998, 95:1213-1217. 10.1073/pnas.95.3.1213, 18722, 9448311.
52. Zhang S, Fantozzi I, Tigno DD, Yi ES, Platoshyn O, Thistlethwaite PA, Kriett JM, Yung G, Rubin LJ, Yuan JX-J. Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2003, 285:L740-L754.
53. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004, 84:767-801. 10.1152/physrev.00041.2003, 15269336.
54. Li S, Sims S, Jiao Y, Chow LH, Pickering JG. Evidence from a novel human cell clone that adult vascular smooth muscle cells can convert reversibly between noncontractile and contractile phenotypes. Circ Res 1999, 85:338-348.
55. Sakao S, Taraseviciene-Stewart L, Wood K, Cool CD, Voelkel NF. Apoptosis of pulmonary microvascular endothelial cells stimulates vascular smooth muscle cell growth. Am J Physiol Lung Cell Mol Physiol 2006, 291:L362-L368. 10.1152/ajplung.00111.2005, 16617095.
56. Bush HJ, Jakubowski JA, Sentissi JM. Neointimal hyperplasia occurring after carotid endarterectomy in a canine model: Effect of endothelial cell seeding vs perioperative aspirin. J Vasc Surg 1987, 5:118-125. 10.1067/mva.1987.avs0050118, 3795378.
57. Conte MS. Endothelial cell resurfacing improves remodeling of balloon-injured arteries in the hypercholesterolemic rabbit. Surg Forum 1996, 47:333-336.
58. Rainger GE, Nash GB. Cellular pathology of atherosclerosis: smooth muscle cells prime cocultured endothelial cells for enhanced leukocyte adhesion. Circ Res 2001, 88:615-622.
59. Zeiffer U, Schober A, Lietz M, Liehn EA, Erl W, Emans N, Yan ZQ, Weber C. Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by P-selectin and chemokines. Circ Res 2004, 94:776-784. 10.1161/01.RES.0000121105.72718.5C, 14963004.
60. Tosh D, Slack JM. How cells change their phenotype. Nature Reviews Molecular Cell Biology 2002, 3:187-194. 10.1038/nrm761, 11994739.
61. Sartore S, Chiavegato A, Faggin E, Franch R, Puato M, Ausoni S, Pauletto P. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling. Circ Res 2001, 89:1111-1121. 10.1161/hh2401.100844, 11739275.
62. Stenmark KR, Durmowicz AG, Dempsey EC. Modulation of vascular wall cell phenotype in pulmonary hypertension. Pulmonary Vascular Remodeling 1995, Portland Press, London, UK, Bishop JE, Reeves JJ, Laurent GJ.
63. Sisbarro L, Ihida-Stansbury K, Stevens T, Bauer N, McMurtry I, Jones PL. The extracellular matrix microenvironment specifies pulmonary endothelial cell identity: roles of tenascin-C and RhoA. Chest 2005, 128. 10.1378/chest.128.6_suppl.564S, 16373827.
64. Majesky MW, Schwartz SM. An origin for smooth muscle cells from endothelium?. Circ Res 1997, 80:601-603.
65. Schwartz SM. Perspectives series: cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest 1997, 99:2814-2817. 10.1172/JCI119472, 508129, 9185501.
66. Arciniegas E, Ponce L, Hartt Y, Graterol A, Carlini RG. Intimal thickening involves transdifferentiation of embryonic endothelial cells. Anat Rec 2000, 258:47-57. 10.1002/(SICI)1097-0185(20000101)258:1<47::AID-AR6>3.0.CO;2-W, 10603448.
67. Zamora MR, Stelzner TJ, Webb S, Panos RJ, Ruff LJ, Dempsey EC. Overexpression of endothelin-1 and enhanced growth of pulmonary artery smooth muscle cells from fawn-hooded rats. Am J Physiol Lung Cell Mol Physiol 1996, 270:L101-L109.
68. Okada K, Bernstein M, Zhang W, Schuster D, Botney M. Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation. Am J Respir Crit Care Med 1998, 158:939-950.
69. Lee SL, Wang WW, Moore BJ, Fanburg BL. Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture. Circ Res 1991, 68:1362-1368.
70. Cool CD, Wood K, Voelkel NF. Transdifferentiation of endothelial cells in primary pulmonary hypertension. Am J Resp Crit Care Med 2004, 167:A844.
71. Sakao S, Taraseviciene-Stewart L, Cool CD, Tada Y, Kasahara Y, Kurosu K, Tanabe N, Takiguchi Y, Tatsumi K, Kuriyama T, Voelkel NF. VEGF-R blockade causes endothelial cell apoptosis, expansion of surviving CD34+ precursor cells and transdifferentiation to smooth muscle-like and neuronal-like cells. FASEB J 2007, 21:3640-3652. 10.1096/fj.07-8432com, 17567571.
72. Frid MG, Kale VA, Stenmark KR. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ Res 2002, 14:1189-1196.
73. Arciniegas E, Sutton AB, Allen TD, Schor AM. Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. J Cell Sci 1992, 103:521-529.
74. Hautmann MB, Adam PJ, Owens GK. Similarities and differences in smooth muscle -actin induction by TGF-s in smooth muscle versus non-smooth muscle cells. Arterioscler Thromb Vasc Biol 1999, 19:2049-2058.
75. Ross R, Glomset JA. Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 1973, 180:1332-1339. 10.1126/science.180.4093.1332, 4350926.
76. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002, 8:403-409. 10.1038/nm0402-403, 11927948.
77. Shimizu K, Sugiyama S, Aikawa M, Fukumoto Y, Rabkin E, Libby P, Mitchell RN. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat Med 2001, 7:738-741. 10.1038/89121, 11385513.
78. Glaser R, Lu MM, Narula N, Epstein JA. Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation 2002, 106:17-19. 10.1161/01.CIR.0000021923.58307.8F, 12093763.
79. Simper D, Stalboerger PG, Panetta CJ, Wang S, Caplice NM. Smooth muscle progenitor cells in human blood. Circulation 2002, 106:1199-1204. 10.1161/01.CIR.0000031525.61826.A8, 12208793.
80. Hu Y, Davison F, Ludewig B, Erdel M, Mayr M, Url M, Dietrich H, Xu Q. mooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 2002, 106:S1834-1839.
81. Hu Y, Mayr M, Metzler B, Erdel M, Davison F, Xu Q. Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions. Circ Res 2002, 91:e13-e20. 10.1161/01.RES.0000037090.34760.EE, 12364395.
82. Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B, Xu Q. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 2004, 113:1258-1265. 398426, 15124016.
83. Aldred MA, Vijayakrishnan J, James V, Soubrier F, Gomez-Sanchez MA, Martensson G, Galie N, Manes A, Corris P, Simonneau G, Humbert M, Morrell NW, Trembath RC. BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension. Hum Mutat 2006, 27:212-213. 10.1002/humu.9398, 16429403.
84. Beck SE, Jung BH, Del Rosario E, Gomez J, Carethers JM. BMP induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK. Cell Signal 2007, 19:1465-1472. 10.1016/j.cellsig.2007.01.017, 17317101.
85. Katoh M. Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis. Stem Cell Rev 2007, 3:30-38. 10.1007/s12015-007-0006-6, 17873379.
86. Ye L, Lewis-Russell JM, Kyanaston HG, Jiang WG. Bone morphogenetic proteins and their receptor signaling in prostate cancer. Histol Histopathol 2007, 22:1129-1147.
87. Stevens T, Gillespie MN. The hyperproliferative endothelial cell phenotype in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 2007, 293:L546-L547. 10.1152/ajplung.00246.2007, 17601794.
88. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell 2007, 128:669-861. 10.1016/j.cell.2007.01.033, 17320505.
89. Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes shape. Cell 2007, 128:635-638. 10.1016/j.cell.2007.02.006, 17320500.
90. Grewal SI, Moazed D. Heterochromatin and epigenetic control of gene expression. Science 2003, 301:798-802. 10.1126/science.1086887, 12907790.
91. Groth A, Rocha W, Verreault A, Almouzni G. Chromatin challenges during DNA replication and repair. Cell 2007, 128:721-733. 10.1016/j.cell.2007.01.030, 17320509.
92. Taraseviciute A, Voelkel NF. Severe pulmonary hypertension in postmenopausal obese women. Eur J Med Res 2006, 11:198-202.
93. Morse JH, Horn EM, Barst RJ. Hormone replacement therapy: a possible risk factor in carriers of familial primary pulmonary hypertension. Chest 1999, 116:847. 10.1378/chest.116.3.847, 10492306.